Search research articles
Contact Us
Filters
Showing results (51-60 of 94) with videos related to
Page
of 10
Sort By:
Blood Advances
|
March 1, 2023
Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis
Farah Mazahreh, Liyan Mazahreh, Carolina Schinke, et al.
Ejhaem
|
May 19, 2023
Variability of definition of high-risk multiple myeloma across phase III clinical trials
Faris Jamal Abu Za'nouneh, Obada Ababneh, Carolina Schinke, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 5, 2026
Choosing Wisely in First Relapse of Multiple Myeloma: Expert Insights on Treatment Selection
Samer Al Hadidi, Caitlin Costello, Luciano J Costa, et al.
Clinical Hematology International
|
October 13, 2025
Treatment Outcomes of Multiple Myeloma in Developing Countries: A Systematic Review and Meta-Analysis
Jehad Almasri, Bashar Hasan, Zin Tarakji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2024
Reflections and Roadmaps: Career Development beyond the FDA-AACR Oncology Educational Fellowship
Timil Patel, Chris Chen, Samer Al Hadidi, et al.
JCO Global Oncology
|
August 12, 2022
Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies
Raleigh Ayoolu Fatoki, Kelly Koehn, Amar Kelkar, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 2, 2024
Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study
Hira Mian, Hsien Seow, Gregory R Pond, et al.
Leukemia & Lymphoma
|
July 19, 2021
Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study
Samer Al Hadidi, Deepa Dongarwar, Hamisu M Salihu, et al.
Haematologica
|
September 4, 2025
The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site study
Michael A Bauer, Phillip Farmer, Joseph L Su, et al.
British Journal of Haematology
|
December 10, 2022
Time-to-event surrogate end-points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis
Tommy Etekal, Kelly Koehn, Douglas W Sborov, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 94) with videos related to
Sort By:
Page
of 10
Blood Advances
|
March 1, 2023
Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis
Farah Mazahreh, Liyan Mazahreh, Carolina Schinke, et al.
Ejhaem
|
May 19, 2023
Variability of definition of high-risk multiple myeloma across phase III clinical trials
Faris Jamal Abu Za'nouneh, Obada Ababneh, Carolina Schinke, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 5, 2026
Choosing Wisely in First Relapse of Multiple Myeloma: Expert Insights on Treatment Selection
Samer Al Hadidi, Caitlin Costello, Luciano J Costa, et al.
Clinical Hematology International
|
October 13, 2025
Treatment Outcomes of Multiple Myeloma in Developing Countries: A Systematic Review and Meta-Analysis
Jehad Almasri, Bashar Hasan, Zin Tarakji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2024
Reflections and Roadmaps: Career Development beyond the FDA-AACR Oncology Educational Fellowship
Timil Patel, Chris Chen, Samer Al Hadidi, et al.
JCO Global Oncology
|
August 12, 2022
Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies
Raleigh Ayoolu Fatoki, Kelly Koehn, Amar Kelkar, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 2, 2024
Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study
Hira Mian, Hsien Seow, Gregory R Pond, et al.
Leukemia & Lymphoma
|
July 19, 2021
Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study
Samer Al Hadidi, Deepa Dongarwar, Hamisu M Salihu, et al.
Haematologica
|
September 4, 2025
The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site study
Michael A Bauer, Phillip Farmer, Joseph L Su, et al.
British Journal of Haematology
|
December 10, 2022
Time-to-event surrogate end-points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis
Tommy Etekal, Kelly Koehn, Douglas W Sborov, et al.
Page
of 10